Your browser doesn't support javascript.
loading
Effect of a home-based inspiratory muscular training programme on functional capacity in patients with chronic COVID-19 after a hospital discharge: protocol for a randomised control trial (InsCOVID trial).
Palau, Patricia; Domínguez, Eloy; Sastre, Clara; Martínez, M Luz; Gonzalez, Cruz; Bondía, Elvira; Albiach, Crtstina; Núñez, Julio; López, Laura.
Afiliación
  • Palau P; Cardiology Department. Hospital Clínico Universitario de Valencia, INCLIVA. Universitat de València, Valencia, Spain patri.palau@gmail.com.
  • Domínguez E; Fisabio. Universitat Jaume I, Castellón, Spain.
  • Sastre C; Cardiology Department. Hospital Clínico Universitario de Valencia, INCLIVA. Universitat de València, Valencia, Spain.
  • Martínez ML; Cardiology Deparment, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Gonzalez C; Pneumology Department, Hospital Clínico Universitario de Valencia. Universitat de València, Valencia, Spain.
  • Bondía E; Pneumology Department, Hospital Clínico Universitario de Valencia. Universitat de València, Valencia, Spain.
  • Albiach C; Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Núñez J; Cardiology Department. Hospital Clínico Universitario de Valencia, INCLIVA. Universitat de València, Valencia, Spain.
  • López L; Physiotherapy Department, Universitat de València, Valencia, Spain.
BMJ Open Respir Res ; 9(1)2022 07.
Article en En | MEDLINE | ID: mdl-35790316
INTRODUCTION: Exercise intolerance and fatigue are the most common symptoms in patients with chronic COVID-19 after hospital discharge. Supervised exercise training programmes improve symptoms, but scarce research has been done on home-based exercise programmes on the maximal functional capacity for discharged symptomatic COVID-19 patients. This study evaluates whether a home-based inspiratory muscle training (IMT) programme improves maximal functional capacity in chronic COVID-19 after hospital admission. METHODS AND ANALYSIS: This single-centre, assessor-blinded randomised controlled trial, powered for superiority, seeks to evaluate maximal functional capacity as the primary endpoint. A total of 26 eligible patients with a previous admission for acute respiratory syndrome coronavirus 2 pneumonia (>3 months after hospital discharge) will be randomised (1:1) to receive a 12-week programme of IMT versus usual care alone. A blinded assessor will measure outcomes at baseline and after the intervention (12 weeks). An analysis of variance will be used to compare continuous outcomes among the two-intervention groups. As of 21 March 2022, eight patients have been enrolled. ETHICS AND DISSEMINATION: The research ethics committee (Comité Ético de Investigación con Medicamentos de l'Hospital Clínic Universitari de València) approved the protocol following the principles of the Declaration of Helsinki and national regulations (Approval Number: 021/226). Findings will be published in peer-reviewed journals and conference publications. TRIAL REGISTRATION NUMBER: NCT05279430.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alta del Paciente / COVID-19 Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Respir Res Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alta del Paciente / COVID-19 Tipo de estudio: Clinical_trials / Guideline Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Respir Res Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido